Good momentum across all businesses and updated Generics guidance

Hikma and Almirall enter an exclusive licensing agreement to market FinjuveTM...

Hikma delivers another year of profitable growth in 2021 and announces...

Hikma continues strong strategic execution and reiterates guidance

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel...

Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition

Hikma and Winterlight Labs PoC Collaboration

Hikma’s diversified business delivers resilient H1 performance

Hikma acquires the rights to a portfolio of Takeda brands for...

Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi...

12Page 1 of 2

Connect with us

1,826FansLike
210FollowersFollow
1,929FollowersFollow
30SubscribersSubscribe